Literature DB >> 7549674

After a first episode of venous thromboembolism.

C N Chesterman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7549674      PMCID： PMC2550712          DOI： 10.1136/bmj.311.7007.700

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Recurrence of venous thromboembolism.

Authors:  W W Coon; P W Willis
Journal:  Surgery       Date:  1973-06       Impact factor: 3.982

Review 2.  Anticoagulants in venous thromboembolism.

Authors:  A Fennerty; I A Campbell; P A Routledge
Journal:  BMJ       Date:  1988-11-19

Review 3.  Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.

Authors:  B Dahlbäck
Journal:  Thromb Haemost       Date:  1995-05       Impact factor: 5.249

4.  The optimal duration of anticoagulant therapy for venous thrombosis.

Authors:  J Hirsh
Journal:  N Engl J Med       Date:  1995-06-22       Impact factor: 91.245

5.  A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

Authors:  S Schulman; A S Rhedin; P Lindmarker; A Carlsson; G Lärfars; P Nicol; E Loogna; E Svensson; B Ljungberg; H Walter
Journal:  N Engl J Med       Date:  1995-06-22       Impact factor: 91.245

6.  Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism.

Authors:  A Gallus; J Jackaman; J Tillett; W Mills; A Wycherley
Journal:  Lancet       Date:  1986-12-06       Impact factor: 79.321

7.  Clinical analysis of 125 patients with the lupus anticoagulant.

Authors:  M Morgan; K Downs; C N Chesterman; J C Biggs
Journal:  Aust N Z J Med       Date:  1993-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.